Stay updated on Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.

Latest updates to the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page
- Check5 days agoChange DetectedFooter revision updated from Revision: v3.5.4 to Revision: v3.5.5, indicating a minor site update that does not affect the study details.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a new revision of the study record metadata.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page’s display footer was updated to reflect a newer ClinicalTrials.gov site revision (v3.5.3) instead of the previous (v3.5.2). This is a versioning/maintenance update rather than a change to the underlying study record details.SummaryDifference0.1%

- Check55 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check83 days agoChange DetectedPage revision updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check91 days agoChange DetectedRevision label updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib-Pemetrexed in Lung, Urothelial, Mesothelioma Clinical Trial page.